Back

Shared epigenetic regulation acting on neuroimmune pathways contributes to the comorbidity between generalized anxiety disorder and COVID-19

Karaca, S.; Cabrera Mendoza, B.; He, J.; Qiu, D.; Davtian, D.; Lacobelle, A.; Nunez, Y. Z.; Krystal, J. H.; Pietrzak, R. H.; Gelernter, J.; Polimanti, R.

2026-06-04 genetic and genomic medicine
10.64898/2026.06.03.26354830 medRxiv
Show abstract

Background: The biological mechanisms linking generalized anxiety disorder (GAD) and COVID-19 remain poorly understood, despite substantial evidence of their comorbidity. To address this gap, we examined genetic and epigenetic factors underlying their co-occurrence. Methods: In a multi-ancestry sample of 893 participants, we conducted genome-wide and epigenome-wide analyses of GAD and COVID-19 severity. Integrating large-scale genome-wide datasets and information regarding methylation quantitative trait loci, complementary analytic approaches were used to identify regional methylation patterns, assess genetically regulated DNA methylation in blood and brain tissue, and evaluate causal loci shared between GAD and COVID-19. Results: GAD was associated with epigenome-wide significant variation in loci involved in chromatin regulation and synaptic signaling. Conversely, COVID-19-related epigenetic signals were enriched in immune-inflammatory and host-response pathways. Mild COVID-19 was epigenetically related to endothelial-inflammatory signals, while severe COVID-19 was linked to epigenetic changes implicated in myeloid and thrombo-inflammatory pathways. Epigenetic signals shared between GAD and COVID-19 implicated processes related to stress adaptation and tissue homeostasis. Genetically informed analyses identified 60 shared loci, including MAPT, ZFP57, and FBXL18, indicating pleiotropy between GAD and COVID-19 in genetically regulated DNA methylation variation. Brain-specific analyses further highlighted convergence in additional loci (i.e., MICB and HLA-DPB1), suggesting neuroimmune mechanisms underlying GAD-COVID-19 shared methylation patterns. Conclusions: These findings support that GAD and COVID-19 share epigenetic and genetic architecture involving pathways related to vascular integrity, immune function, and cellular adaptation, highlighting a potential neuroimmune basis for their co-occurrence.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Translational Psychiatry
219 papers in training set
Top 0.2%
17.2%
2
Molecular Psychiatry
242 papers in training set
Top 0.1%
14.5%
3
Clinical Epigenetics
53 papers in training set
Top 0.1%
14.1%
4
Brain, Behavior, and Immunity
105 papers in training set
Top 0.3%
6.7%
50% of probability mass above
5
Biological Psychiatry
119 papers in training set
Top 0.6%
6.2%
6
European Neuropsychopharmacology
15 papers in training set
Top 0.1%
4.8%
7
Brain, Behavior, & Immunity - Health
27 papers in training set
Top 0.1%
3.5%
8
Psychological Medicine
74 papers in training set
Top 0.7%
2.7%
9
Nature Communications
4913 papers in training set
Top 45%
2.6%
10
American Journal of Psychiatry
20 papers in training set
Top 0.1%
1.8%
11
Scientific Reports
3102 papers in training set
Top 59%
1.7%
12
Neuropsychopharmacology
134 papers in training set
Top 2%
1.3%
13
Neurobiology of Disease
134 papers in training set
Top 3%
1.3%
14
Journal of Affective Disorders
81 papers in training set
Top 1%
0.9%
15
British Journal of Anaesthesia
14 papers in training set
Top 0.6%
0.9%
16
Neurobiology of Stress
42 papers in training set
Top 0.4%
0.8%
17
Biological Psychiatry Global Open Science
54 papers in training set
Top 2%
0.7%
18
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.4%
0.7%
19
Journal of Internal Medicine
12 papers in training set
Top 0.7%
0.7%
20
Frontiers in Genetics
197 papers in training set
Top 10%
0.7%
21
Brain
154 papers in training set
Top 5%
0.6%